NationsHealth, Inc. (Nasdaq: NHRX; NHRXW; NHRXU) today announced
its financial results for its fourth quarter and year ended
December 31, 2006. Revenue for the quarter ended December 31, 2006
was $22.8 million compared to $25.2 million for the corresponding
period in 2005. Net income for the quarter ended December 31, 2006
was $1.2 million, or $0.04 per diluted share, compared to a net
loss of $17.9 million, or $0.67 per share, for the corresponding
period in 2005. For the year ended December 31, 2006, revenue was
$87.2 million compared to $87.6 million for 2005. Net loss for 2006
was $11.3 million, or $0.40 per share, compared to a net loss of
$19.8 million, or $0.75 per share, for 2005. Revenue for the year
ended December 31, 2005 included approximately $19.0 million from
the Company�s respiratory division, which was sold on September 2,
2005. Net loss for 2005 also included a gain of approximately $15.5
million from the sale of the respiratory division. Net loss for
2006 includes a gain of $5.0 million from the sale of the Company�s
discount prescription drug card business, which was sold on
September 5, 2006. Adjusted EBITDA*, defined as income before
interest, taxes, depreciation and amortization, stock based
compensation, non-cash impairment charges and gains on the sale of
business lines, was $3.8 million for the quarter ended December 31,
2006, compared to adjusted EBITDA of $4.4 million for the quarter
ended September 30, 2006, which included a gain of approximately
$1.0 million on the settlement of a vendor obligation. Adjusted
EBITDA for the quarter ended December 31, 2006 includes a $0.5
million charge for executive severance and the reversal of
approximately $0.8 million related to year-end bonus amounts that
had been accrued in prior quarters. The Company�s Insurance
Services segment contributed profit of $4.4 million for the quarter
ended December 31, 2006, compared to profit of $3.7 million for the
quarter ended September 30, 2006. The Medical Products segment
contributed profit of $2.2 million for the quarter ended December
31, 2006, compared to profit of $3.4 million for the quarter ended
September 30, 2006 including the $1.0 million gain on the vendor
settlement. For the year ended December 31, 2006, the Insurance
Services segment contributed profit of $2.6 million and the Medical
Products segment contributed profit of $9.5 million. During 2006
and continuing through the fourth quarter, NationsHealth took a
number of steps to better align the Company�s focus on its core
business segments, improve operating results and cash flow, and
strengthen its balance sheet, including the following: The Company
underwent a management restructuring and implemented a number of
cost containment and efficiency initiatives throughout the year,
resulting in, among other things, a significant reduction in
corporate overhead and improvements in operating margins; In May
2006, the Company amended and restated its agreement with CIGNA
whereby it will be reimbursed under a predictable service fee
arrangement for services provided to CIGNA starting with the 2007
Medicare Part D plan year and beyond. Additionally, the amended
agreement permits the Company to provide similar services to other
Medicare insurance providers; In September 2006, the Company sold
its discount prescription drug card business for $6.0 million. With
the widespread adoption of the Medicare Part D program, the
discount prescription card business was a declining revenue stream
that was no longer core or complementary to the Company�s Medical
Products and Insurance Services segments; Also in September 2006,
the Company terminated a distribution agreement with a vendor,
pursuant to which the Company paid the vendor approximately $4.4
million in full satisfaction of approximately $5.4 million due
under the agreement and relieved itself of remaining purchase
obligations under the agreement totaling approximately $27 million;
Throughout the second half of 2006, the Company expanded the
breadth of offerings to its existing medical products patient base
to include insulin and syringes, heating pads and oral medications.
In addition, the Company began accepting patients who have Medicaid
as their primary insurance and added relationships with managed
care organizations, thereby expanding opportunities to increase its
patient base; As permitted under the amended agreement with CIGNA,
during the fourth quarter of 2006, the Company entered into
agreements to provide Medicare insurance related services to four
new clients, resulting in revenue of approximately $3.3 million for
the quarter. �We are extremely pleased that the changes we
implemented in our business operations in 2006 enabled us to
generate net income and positive cash from operations in the fourth
quarter of 2006,� said Timothy Fairbanks, the Company�s Chief
Financial Officer. �During 2007 we will continue to focus on our
core competencies and expanding our product offerings and payor
sources within our two existing business segments.� As previously
announced, NationsHealth will host a conference call at 2:00 p.m.
EDT today to review its financial results for the quarter and year
ended December 31, 2006. Access Information: Date: March 15, 2007
Time: 2:00 p.m. ET U.S./Canada dial-in number: 877-704-5386
International dial-in number: 913-312-1302 Participant passcode:
4855030 Live webcast: www.nationshealth.com Replay Access
Information: A recording of the conference call will be available
three hours after completion until March 22, 2007 at midnight ET at
888-203-1112 (U.S.) and 719-457-0820 (International). The replay
passcode is 4855030. The webcast will be archived for on demand
listening for 30 days on the NationsHealth�s website,
www.nationshealth.com. About NationsHealth, Inc. NationsHealth
seeks to improve the delivery of healthcare to Medicare and managed
care beneficiaries by providing medical products and prescription
related services. NationsHealth provides home delivery of diabetes
supplies, medications and other medical products to patients across
the nation. NationsHealth is also the provider of diabetes supplies
to Medicare beneficiaries at over 1,100 Kmart pharmacies. In
addition to its medical products business, NationsHealth also
provides education, marketing, enrollment and patient service to
insurers offering Medicare Part D prescription drug plans and other
Medicare insurance coverage. NationsHealth has an agreement with
CIGNA to service its Medicare Part D prescription drug plans
nationally. For more information please visit
http://www.nationshealth.com. * Use of Non-GAAP Financial Measures
In its earnings releases, conference calls, slide presentations or
webcasts, the Company may use or discuss adjusted EBITDA, which is
a non-GAAP financial measure as defined by SEC Regulation G.
Management regularly reviews adjusted EBITDA as an analytical
indicator of the Company�s financial performance and believes that
it is useful to investors in evaluating operating performance. In
addition, the Company uses adjusted EBITDA as a measure of
performance for its business segments and for incentive
compensation purposes. The Company does not intend for adjusted
EBITDA to be considered in isolation or as a substitute for any
GAAP measure. Adjusted EBITDA, as presented, may not be comparable
to similarly titled measures of other companies. Net income is the
GAAP financial measure most directly comparable to adjusted EBITDA.
A reconciliation of adjusted EBITDA to net income is as follows (in
thousands): Three Months Ended December 31,2006 September 30,2006
Net income $ 1,229� $ 6,020� Interest, net 829� 778� Depreciation
and amortization 467� 488� Amortization of deferred contract
acquisition costs 969� 969� Stock-based compensation 334� 585�
Non-cash impairment charge -� 559� Gain on sale of business line �
-� � (5,000) Adjusted EBITDA $ 3,828� $ 4,399� This press release
contains forward-looking statements about NationsHealth, including
statements regarding management initiatives, efforts to streamline
operations and reduce costs and new product and market
opportunities, none of which should be construed in any manner as a
guarantee that such results will in fact occur. In addition, other
written or oral statements that constitute forward-looking
statements may be made by us or on our behalf. Forward-looking
statements are statements that are not historical facts, and in
some cases may be identified by the words �anticipate,� �project,�
�expect,� �plan,� �intend,� �may,� �should,� �will,� and similar
words or phrases. Such forward-looking statements, based upon the
current beliefs and expectations of NationsHealth�s management, are
subject to risks and uncertainties, which could cause actual
results to differ from the forward-looking statements. The
following factors, among others, could cause actual results to
differ from those set forth in the forward-looking statements: our
ability to maintain our existing customer base; our dependence on
Medicare reimbursement; our customers� desire to take advantage of
our Part D and specialty pharmacy services; uncertainty in our
costs incurred in administering the Part D program; changes in
Medicare, Medicaid, Tricare, Champus and any other state or
national-based reimbursement program, including competitive bidding
for durable medical equipment and supplies; changing
interpretations of generally accepted accounting principles;
outcomes of government reviews of NationsHealth�s business
practices; inquiries and investigations and related litigation;
continued compliance with government regulations; legislation or
regulatory requirements or changes adversely affecting the
businesses in which NationsHealth is engaged; fluctuations in
customer demand; management of rapid growth; our ability to compete
effectively; timing and market acceptance of new products sold by
NationsHealth; general economic conditions; and geopolitical
events, regulatory changes and other risks and uncertainties
described in NationsHealth�s Annual Report on Form 10-K for the
year ended December 31, 2005, Quarterly Report on Form 10-Q for the
quarters ended March 31, 2006, June 30, 2006 and September 30, 2006
and NationsHealth�s other reports filed with the Securities and
Exchange Commission. The information set forth herein should be
read in light of such risks. NationsHealth cautions investors not
to place undue reliance on the forward-looking statements contained
herein. These statements speak only as of the date of this press
release and, except as required by applicable law, NationsHealth
assumes no obligation to update the information contained herein.
SUMMARY CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In
thousands, except per share data) � Three Months EndedDecember 31,
� 2006� � 2005� Revenue: Net product sales $ 11,233� $ 13,389�
Prescription drug card revenue --� 2,292� Service revenue � 11,556�
� 9,469� 22,789� 25,150� � Cost of product sales 4,430� 6,241� Cost
of services � 6,222� � 20,908� � Gross Profit (Loss) � 12,137� �
(1,999) � Operating Expenses: Patient acquisition and related costs
590� 101� Patient service and fulfillment 1,903� 3,009� General and
administrative 5,512� 11,130� Provision for doubtful accounts 781�
--� Depreciation and amortization 324� 327� Amortization of
deferred contract acquisition costs � 969� � 646� � 10,079� �
15,213� � Income (Loss) from Operations 2,058� (17,212) � Other
Expense, net � (829) � (725) � Net Income (Loss) $ 1,229� $
(17,937) � Earnings (loss) per share � basic and diluted $ 0.04� $
(0.67) � Weighted average shares outstanding - basic and diluted
27,964� 26,742� SUMMARY CONSOLIDATED STATEMENTS OF OPERATIONS (In
thousands, except per share data) � Year EndedDecember 31, � 2006�
� 2005� (Unaudited) Revenue: Net product sales $ 44,788� $ 68,688�
Prescription drug card revenue 3,983� 8,619� Service revenue �
38,445� � 10,249� 87,216� 87,556� � Cost of product sales 18,854�
29,689� Cost of services � 31,907� � 22,219� � Gross Profit �
36,455� � 35,648� � Operating Expenses: Patient acquisition and
related costs 3,382� 18,077� Patient service and fulfillment 8,286�
14,427� General and administrative 27,940� 26,323� Provision for
doubtful accounts 3,625� 7,575� Depreciation and amortization
1,353� 980� Amortization of deferred contract acquisition costs
3,878� 646� Impairment of investment in joint venture 1,292� --�
Gain on sales of business lines � (5,000) � (15,508) � 44,756� �
52,520� � Loss from Operations (8,301) (16,872) � Other Expense,
net � (2,977) � (2,947) � Net Loss $ (11,278) $ (19,819) � Loss per
share � basic and diluted $ (0.40) $ (0.75) � Weighted average
shares outstanding - basic and diluted � 27,895� � 26,345� SUMMARY
CONSOLIDATED BALANCE SHEETS (In thousands) � December 31, December
31, 2006� 2005� (Unaudited) ASSETS Current Assets: Cash and
short-term investments $ 4,224� $ 14,894� Accounts receivable, net
6,075� 7,908� Inventory 1,636� 1,285� Costs related to billings in
process, net 565� 874� Other receivables 219� 1,877� Prepaid
expenses and other current assets � 529� � 750� Total current
assets 13,248� 27,588� Property and equipment, net 3,557� 3,747�
Investment in joint venture --� 1,488� Deferred contract
acquisition costs, net 11,632� 15,510� Other assets, net � 1,951� �
1,526� Total assets $ 30,388� $ 49,859� � LIABILITIES AND
STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,026�
$ 13,387� Accrued expenses 9,069� 12,030� Deferred revenue, current
portion --� 235� Line of credit � 2,500� 2,500� Total current
liabilities � 14,595� 28,152� � Long-Term Liabilities: Deferred
revenue --� 1,100� Convertible notes, related party, net 6,316�
5,176� Promissory note payable, net 1,328� --� Other long-term
liabilities � 782� � 1,414� Total long-term liabilities � 8,426� �
7,690� � Stockholders' Equity � 7,367� � 14,017� Total liabilities
and stockholders' equity $ 30,388� $ 49,859�
Nationshealth (NASDAQ:NHRXU)
Historical Stock Chart
From May 2024 to Jun 2024
Nationshealth (NASDAQ:NHRXU)
Historical Stock Chart
From Jun 2023 to Jun 2024